Alliance Boots

Alliance Boots is a Swiss chemicals and health care group with British roots, as well as one of the leading pharmaceutical wholesaler in Europe.

Alliance Boots was awarded his company's name through the merger of Boots the Chemists and Alliance UniChem after completion of the merger on 31 July 2006. Previously, the Group's Boots Group plc name. Strictly speaking, acquired Boots Group plc. Alliance UniChem plc currently. The Group marketed under the brand name "Boots", medical products, and has the Alliance Pharmacy, a chemical company and wholesaler of pharmaceutical products with over 1000 sales transactions.

It is planned in the future to carry out all transactions of the Group under the brand name boots. Alliance Boots is the largest group in the UK, the pharmaceutical products sold and has also sell chains, investments and joint ventures in 21 countries. Profit in the financial year 2012/13 (after taxes): GBP 805 million. In addition to pharmaceuticals Alliance Boots also sells cosmetics with its own brand name Soltan, No7 and Botanics. In addition to this additional offer for Alliance Boots pharmacy has gone into the production of generic drugs, which are marketed under the brand name Almus.


Alliance Boots is divided its operations into two divisions

Direct or indirect sales presence in 11 countries with more than 3280 sales outlets, of which also include nearly 3180 a pharmacy. In the same division, the 655 opticians in the UK are managed.

Boots operates 370 distribution centers in 21 countries, making it Europe's largest pharmaceutical wholesaler. Typically, Alliance Boots thus ranks among the three largest wholesalers each country.


By buying up shares of Andreae -Noris Zahn AG ( ANZAG ) in late 2010, which were owned by Celesio, Sanacorp and Phoenix before, the Alliance Boots with about 82 % of the shares was the majority owner of the third largest pharmaceutical wholesaler in Germany. In the same year (2010 /11), the group expanded into Turkey through a majority stake in Hedef Alliance, the largest pharmaceutical wholesalers in the country. Since June 2012, it owns more than 95 % of ANZAG shares. On 18 December 2012, the squeeze -out procedure for the remaining shareholders was approved by the last General Meeting of ANZAG. On April 1, 2013, the ANZAG was renamed Alliance Healthcare Germany.

Acquisition by KKR and Stefano Pessina

Alliance Boots was listed until end of April 2007 on the London Stock Exchange and constituent of the FTSE 100 to its acquisition by a consortium consisting of the private equity firm KKR and Stefano Pessina, a member of the founding family of Alliance UniChem and former CEO of the company, the together to invest the equivalent of 16.2 billion euros.